Early versus delayed or no empagliflozin initiation after hospitalisation for heart failure in the United States: A target trial emulation.
Stephen J Greene, Giorgi Tskhvarashvili, Phuong Tran, Ruben Hermans, Shirin Enshaeifar, Atif Adam, Monica Martinez Traba, Niklas Schmedt, Ayman Alhamdow PMID: 42770322 DOI: 10.1093/eschf/xvag242 Background Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are